SE:CAMX Stock Latest News
Company AnnouncementsCamurus Earnings Call Highlights Growth Despite FDA Uncertainty1w ago
Company AnnouncementsCamurus Reports Strong Growth and Regulatory Progress2w ago
Company AnnouncementsCamurus Sets Nomination Committee and Timetable for 2027 AGM2M ago
Company AnnouncementsCamurus’ Acromegaly Drug CAM2029 Resubmission Accepted by U.S. FDA4M ago
Company AnnouncementsCamurus AB Earnings Call Highlights Growth And Risks4M ago
Company AnnouncementsCamurus Delivers Record Product Sales and Strengthens Cash While Deepening Lilly Collaboration4M ago
Company AnnouncementsCamurus hit by FDA manufacturing setback on U.S. acromegaly drug filing5M ago
Company AnnouncementsCamurus Wins Lilly Option Exercise, Extending Long-Acting Cardiometabolic Drug Deal5M ago
Company AnnouncementsCamurus Repurchases Series C Shares to Fund Long-Term Incentive Plan5M ago
Company AnnouncementsCamurus AGM Backs Board, Withholds Dividend and Approves New Performance Share Plan5M ago
Company AnnouncementsCamurus calls 2026 AGM with capital measures and new incentive plan on agenda6M ago
Company AnnouncementsCamurus Expands Share Capital After Employee Stock Option Exercises7M ago
Company AnnouncementsCamurus Expands Share Capital After Employee Stock Option Exercises8M ago
Company AnnouncementsCamurus Strengthens Executive Team With New Corporate Development Chief9M ago
Company AnnouncementsCamurus AB Earnings Call: Growth, FX and U.S. Push9M agoCompany AnnouncementsCamurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio9M ago


